GOOD DESIGN AWARD

閉じる
キーワード
受賞年度
年度(から 年度まで)
特別賞
企業情報
CC

2009

GOOD DESIGN|グッドデザイン賞

受賞対象名
NovoTwist injection pen needle [NovoTwist]
事業主体名
Novo Nordisk A/S
領域/分類
社会領域 - 医療関連機器設備
受賞企業
Novo Nordisk A/S (Denmark)
受賞番号
09D01003
受賞概要
2009年度グッドデザイン賞受賞概要

受賞対象の概要※掲載している情報は、受賞当時の情報のため、現在は異なる場合があります。

概要

NovoTwist is a new needle for Next Generation FlexPen and has a unique bayonet fitting. Users simply align the needle and pen, push them together, twist and click them in place. An integrated glue tower makes the needle appear shorter and provides lateral flexibility and support to reduce the risk of breakage. A flanged inner cap protects the patient's fingers and minimises the risk of needle-stick injury. A ribbed outer cap aids the patient's grip and can be used for attaching and removing the needle.

プロデューサー

Henrik Klint, Steffen Lav, Lars Skouboe/Novo Nordisk A/S

ディレクター

Henrik Klint, Steffen Lav/ Novo Nordisk A/S

デザイナー

Scott Allen, Tue Toft, Peter Moller-Jensen/ Moller-Jensen Design

All designers

詳細情報

http://www.novonordisk.com/diabetes/hcp/needles/novotwist/NovoTwist-default.asp

発売
2009年6月6日
価格

250Danish Krone (250 DKK per 100 needles (2.5 DKK each))

販売地域

国外市場向け

設置場所

First launch South Africa - June 2009. Anticipated Global Launch to follow

受賞対象の詳細

応募対象が達成しようとした目標

Healthcare professionals and patients who use needles with insulin injection pens often ask for greater ease of attachment. This was identified as the single feature to make the greatest difference to them. The means of attachment has been addressed in the design of NovoTwist. It was designed for simplicity, with its unique 'Just Twist' needle attachment.

デザイナーのコメント

Our initial objective was to listen and respond to the users. In so doing, we had to consider their treatment regimens and interaction with an injecting device. The final solution required a number of features that gave clear signals to the user. We also had to meet the demands of a complex design on a small scale. In parallel was the challenge of ensuring compatibility with a number of devices.

使用者、社会等への取り組み

どのような使用者・利用者を想定したか

Users will initially be people with diabetes using the Next Generation FlexPen for insulin injection. Other pen devices from Novo Nordisk for insulin injection and injection pens for other diseases will subsequently become compatible with NovoTwist.

その使用者・利用者にどのような価値を実現したか

Patients with diabetes often have problems with manual dexterity and find conventional screw-thread needle attachment difficult. The 'just twist' attachment of the new pen needle resulted in 3 out of 4 patients preferring NovoTwist to conventional screw-thread needles in two separate surveys (Sommavilla et al, 2008; Lytzen & Ostfeldt, 2009).

社会・文化および地球環境の視点から解決すべき問題点

By making the attachment and detachment of needles to insulin injection pens easier and faster, NovoTwist helps tackle the stigma associated with self-injection and allows more discreet use of such pens.

その問題点に対し、どのように対応したか

There is a stigma associated with self-injecting any medication, especially if this has to be done in public.

どこで購入できるか、
どこで見られるか

Novo Nordisk A/S, Hummeltoftevej 49, DK-2830 Virum, Denmark
http://www.novonordisk.com

審査委員の評価

従来の螺子状の針は特に高齢者は螺子山にうまく入れることができない、針の装着、取り外し時に何回も回転動作を加える必要があったため手先がうまく動かない、力が加え難いなど多くの課題を抱えていた。NovoTwistはこの問題を解決したもので、挿入と捻りで装着完了することができる。従来の課題を解決し、全体のデザインを機能的にまとめた点が評価された。

担当審査委員| 和田 達也   大月 ヒロ子   橋田 規子   日高 一樹  

ページトップへ